Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 682 Records) |
| Query Trace: Lung Neoplasms and ALK[original query] |
|---|
| Registry of Genetic Alterations of Taiwan Non-Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521. JCO global oncology 2024 9 10 e2400125. Bin-Chi Liao, Nai-Jung Chiang, Gee-Chen Chang, Wu-Chou Su, Yung-Hung Luo, Inn-Wen Chong, Tsung-Ying Yang, Chun-Liang Lai, Te-Chun Hsia, Ching-Liang Ho, Kang-Yun Lee, Chin-Fu Hsiao, Fan-Chen Ku, Wei-Tse Fang, James Chih-Hsin Ya |
| Clinical Utility of Circulating Tumor DNA for Detecting Lung Cancer Mutations by Targeted Next-Generation Sequencing With Insufficient Tumor Samples. Journal of clinical laboratory analysis 2024 9 e25099. Yi Sun, Xu Zhang, Xinhua Yang, Jiangjun |
| Clinical and Genetic Characteristics of Early-onset Lung Adenocarcinoma in a Large Chinese Cohort. The Annals of thoracic surgery 2024 9 . Shouzhi Xie, Qikang Hu, Zeyu Wu, Bin Wang, Yu He, Qi Huang, Zhe Zhang, Zhi Yang, Shengrong Wu, Weiyu Yang, Xinhang Hu, Xuyang Yi, Hao He, Cheng Wang, Fenglei Yu, Muyun Pe |
| Tumor markers in non-small cell lung cancer spine metastasis: an assessment of prognosis and overall survival. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 2024 9 . Brian Foresi, Aakash Shah, Seth Meade, Ajit Krishnan |
| Outcomes with non-small cell lung cancer and brain-only metastasis. Heliyon 2024 9 10 (17): e37082. Sabine Schmid, Miguel Garcia, Luna Zhan, Sierra Cheng, Khaleeq Khan, Maisha Chowdhury, Amir Sabouhanian, Joshua Herman, Preet Walia, Evan Strom, M Catherine Brown, Devalben Patel, Wei Xu, Frances A Shepherd, Adrian G Sacher, Natasha B Leighl, Penelope A Bradbury, Geoffrey Liu, David Shul |
| Proteogenomic characterization identifies clinical subgroups in EGFR and ALK wild-type never-smoker lung adenocarcinoma. Experimental & molecular medicine 2024 9 . Hyondeog Kim, Wonyeop Lee, Youngwook Kim, Sang-Jin Lee, Wonyoung Choi, Geon Kook Lee, Seung-Jin Park, Shinyeong Ju, Seon-Young Kim, Cheolju Lee, Ji-Youn H |
| Evaluation of the novel International Association for the Study of Lung Cancer grading system in adenocarcinoma with spread through air space. Translational lung cancer research 2024 9 13 (8): 1862-1876. Kuan Xu, Yilv Lv, Tangbing Chen, Yuchen Han, Hanqing Huang, Hong Yu, Bo |
| Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role of genetic risk. Lung cancer (Amsterdam, Netherlands) 2024 8 195 107920. Virginia Calvo, Emetis Niazmand, Enric Carcereny, Delvys Rodriguez-Abreu, Manuel Cobo, Rafael López-Castro, María Guirado, Carlos Camps, Ana Laura Ortega, Reyes Bernabé, Bartomeu Massutí, Rosario Garcia-Campelo, Edel Del Barco, José Luis González-Larriba, Joaquim Bosch-Barrera, Marta Martínez, María Torrente, María-Esther Vidal, Mariano Provenc |
| Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis. Neoplasia (New York, N.Y.) 2024 12 60 101113. Sheng-Kai Liang, Wei-Yu Liao, Jin-Yuan Shih, Chia-Lin Hsu, Ching-Yao Yang, Shang-Gin Wu, Yen-Ting Lin, Yueh-Feng Wen, Lun-Che Chen, Yen-Fu Chen, Ya-Fang Chen, Yen-Heng Lin, Chong-Jen |
| Outcomes of patients receiving urgent palliative radiotherapy for advanced lung cancer: an observational study. BMC palliative care 2024 12 23 (1): 296. Yang Xu, Celestee Trach, Tracey Tessier, Rishi Sinha, David Skarsga |
| Genetic profile in primary tumor tissue of advanced lung adenocarcinoma patients with adrenal metastasis. Cancer genetics 2024 12 290-291 36-43. Haiqiao Pan, Hongbin Zhang, Yongqian Zhang, Xiaojing Chen, Zhai Liu, Yajing Wu, Na Bai, Yan Shi, Min Zhao, Lingling Z |
| Prognostic impact of targetable driver alterations in resected early-stage lung cancer. Translational lung cancer research 2024 12 13 (11): 3096-3105. Angelika Terbuch, Selma Konjic, Verena Schlintl, Gudrun Absenger, Philipp J Jost, Jörg Lindenmann, Paul Swatek, Nikolaus John, Teresa John, Robert Wurm, Martin Zacharias, Florian Posch, Maximilian J Hochmair, Hannah Fabikan, Christoph Weinlinger, Oliver Illini, Lena Horvath, Gabriele Gamerith, Dominik Wolf, Florian Augustin, Luka Brc |
| Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1. Frontiers in oncology 2024 12 14 1473327. Zachary D Wallen, Mary K Nesline, Marni Tierno, Alison Roos, Erica Schnettler, Hatim Husain, Pratheesh Sathyan, Brian Caveney, Marcia Eisenberg, Eric A Severson, Shakti H Ramkisso |
| Sex and common germline variants impact the toxicity profile and pharmacokinetics of alectinib: a nation-wide cohort study in patients with ALK-positive non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 12 . Niels Heersche, Daan A C Lanser, M Benthe Muntinghe-Wagenaar, Ma Ida Mohmaed Ali, Ezgi B Ulas, Tessa M A Trooster, Evert de Jonge, Esther Oomen-de Hoop, Marthe S Paats, Idris Bahce, Sander Croes, Lizza E L Hendriks, Anthonie J van der Wekken, Anne-Marie C Dingemans, Alwin D R Huitema, Ron H N van Schaik, Ron H J Mathijssen, G D Marijn Veerm |
| The Prevalence of Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Cancer: An Experience From Tertiary Care Hospital. Cureus 2024 11 16 (10): e72291. Asmita Mehta, Lakshmi Priya V P, Lakshmi Teja, Krishna Pill |
| Brief Report: Final overall survival and long-term safety of lorlatinib in patients with ALK-positive non-small cell lung cancer from the pivotal phase 2 study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 11 . Sai-Hong Ignatius Ou, Benjamin J Solomon, Benjamin Besse, Alessandra Bearz, Chia-Chi Lin, Rita Chiari, D Ross Camidge, Jessica J Lin, Antonello Abbattista, Francesca Toffalorio, Ross A S |
| Cytomorphological and histomorphological features of lung adenocarcinoma with epidermal growth factor receptor mutation and anaplastic lymphoma kinase gene rearrangement. Oncology letters 2024 11 29 (1): 40. Nikola Gardi?, Aleksandra Lovrenski, Vanesa Sekeruš, Svetlana Kašikovi? Le?i?, Milorad Bijelovi?, Tanja Laki?, Aleksandra Ili?, Bojan Zari?, Sofija Glum |
| Landscape of C-MET overexpression in non-small cell lung cancer: a large-scale study of clinicomolecular features and prognosis based on Chinese data. Therapeutic advances in medical oncology 2024 10 16 17588359241279715. Shuting Zhan, Jianfu Li, Bo Cheng, Caichen Li, Yi Feng, Lei Fan, Shan Xiong, Wenchuang Zeng, Qi Cai, Yang Xiang, Huiting Wang, Chunyan Li, Peiling Chen, Xin Zheng, Wenhai Fu, Zhexue Hao, Jianxing He, Wenhua Lia |
| Inadequate staging and excessive surveillance imaging: Evaluating the magnitude of benefit of targeted therapies in lung cancer. European journal of cancer (Oxford, England : 1990) 2024 10 212 115058. David J Benjamin, Vinay Pras |
| [Clinical characteristics and prognostic factors of epidermal growth factor receptor-mutated non-small cell lung cancer transformed into small-cell lung cancer after treatment]. Zhonghua yi xue za zhi 2024 10 104 (40): 3751-3756. H Zheng, D Zhao, M Gu, Q H Wang, C H Li, X Li, J Li, N Y Che, Y |
| Epidemiological and clinical characteristics of lung cancer in Saudi Arabia: a retrospective study in single oncology center. Oncology research 2024 10 32 (11): 1803-1809. Yousef Katib, Nasser Mul |
| Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer. Journal for immunotherapy of cancer 2024 10 12 (10): . Nicolas Zhou, Cheuk H Leung, William N William, Annikka Weissferdt, Apar Pataer, Myrna C B Godoy, Brett W Carter, Frank V Fossella, Anne S Tsao, George R Blumenschein, Xiuning Le, Jianjun Zhang, Ferdinandos Skoulidis, Jonathan M Kurie, Mehmet Altan, Charles Lu, Bonnie S Glisson, Lauren A Byers, Yasir Y Elamin, Reza J Mehran, David C Rice, Garrett L Walsh, Wayne L Hofstetter, Jack A Roth, Hai T Tran, Jia Wu, Luisa M Solis Soto, Humam Kadara, Stephen G Swisher, Ara A Vaporciyan, Don L Gibbons, Heather Y Lin, J Jack Lee, John V Heymach, Marcelo V Negrao, Boris Sepesi, Tina Casco |
| Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia. Lung cancer (Amsterdam, Netherlands) 2024 10 197 107992. Yuki Kato, Hibiki Udagawa, Shingo Matsumoto, Hiroki Izumi, Yuichiro Ohe, Terufumi Kato, Kazumi Nishino, Shingo Miyamoto, Sachiko Kawana, Kenichi Chikamori, Masato Shingyoji, Yuki Sato, Yuji Takada, Ryo Toyozawa, Koichi Azuma, Yu Tanaka, Tetsuya Sakai, Yuji Shibata, Eri Sugiyama, Kaname Nosaki, Yoshitaka Zenke, Shigeki Umemura, Kiyotaka Yoh, Masahiro Seike, Koichi Go |
| Adenosquamous Carcinoma of the Lung: Survival, Radiologic Findings, PD-L1, and Driver Mutations. Journal of clinical medicine 2024 10 13 (19): . Oliver Illini, Hannah Fabikan, Eva Fischer, Anna Sophie Lang-Stöberl, Dagmar Krenbek, Christa Jarius, Shokoufa Azarnia-Medan, Stefan Gasser, Maximilian Johannes Hochmair, Christoph Weinlinger, Arschang Valipour, Stefan Watz |
| Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial. The Lancet. Oncology 2025 1 26 (1): 74-84. Yanjun Xu, Kaiyan Chen, Yujin Xu, Hui Li, Zhiyu Huang, Hongyang Lu, Dingzhi Huang, Sizhe Yu, Na Han, Lei Gong, Jing Qin, Jun Chen, Fajun Xie, Wei Hong, Xiao Lin, Fengzhuo Cheng, Xiaojie Luo, Yun F |
| Brief report: Impact of consolidation durvalumab on unresectable non-small lung cancer with driver mutations. Cancer treatment and research communications 2025 1 42 100863. Jason C S Ho, K M Cheu |
| Non small cell lung cancer with SMARCA4 deficiency harboring rare EGFR mutations exhibited significant tumor response when treated with afatinib: a case report. Frontiers of medicine 2025 1 . Xiaotong Qiu, Liangkun You, Chongwei Wang, Jin She |
| Real-World Incidence of Anaplastic Lymphoma Kinase alterations in Hispanics with Non-Small Cell Lung Cancer at a Large Academic Institution in Los Angeles. Cancer research communications 2025 1 . Darin Poei, Sana Ali, Jacob S Thomas, Jorge J Nieva, Robert C H |
| RET-AREAL: a multi-center, real-world data analysis on the efficacy of pralsetinib in acquired RET fusion after resistance to EGFR/ALK-TKIs. Cancer letters 2025 1 217455. Xinjun Tang, Jie Hu, Renhua Guo, Yina Wang, Yu Yao, Liang Zeng, Haitao Wang, Haibo Shen, Jun Chen, Weina Huang, Lihua Liu, Ming Su, Zhuang Yu, Weidong Mao, Jinliang Wang, Haitao Tao, Guilan Dong, Chang Cai, Yupeng Xie, Tao Qu, Yan Zhang, Wei Shen, Jing Cao, Xin Cai, Wencui Kong, Xiaoxue Li, Fei Lia |
| Enhanced detection of actionable mutations in NSCLC through pleural effusion cell-free DNA sequencing: A prospective study. European journal of cancer (Oxford, England : 1990) 2025 1 217 115224. Hsin-Yi Wang, Wei-Yu Liao, Chao-Chi Ho, Shang-Gin Wu, Ching-Yao Yang, Chia-Lin Hsu, Yen-Ting Lin, James Chih-Hsin Yang, Jin-Yuan Sh |
- Page last reviewed:Feb 1, 2024
- Content source: